Table 3

Abnormal Involuntary Movement Scale (AIMS) scores at baseline and after 6 and 12 wk of treament with loxapine, n = 24

Symptom, time	Mean score (and SD)	Range	Repeated ANOVA p value
Facial and oral movements
Baseline	2.67 (4.05)	0–14	0.47
6 wk	2.08 (3.19)	0–12
12 wk	2.00 (3.24)	0–12
Extremity movements
Baseline	0.17 (1.97)	0–7	0.006^*
6 wk	0.33 (0.96)	0–4
12 wk	0.21 (0.59)	0–2
Trunk movements
Baseline	0.29 (1.00)	0–4	0.51
6 wk	0.17 (0.82)	0–4
12 wk	0.25 (0.85)	0–3
Global judgements
Baseline	1.79 (2.34	0–8	0.06
6 wk	1.00 (1.79)	0–6
12 wk	0.88 (1.51)	0–5
Total
Baseline	5.92 (7.83)	0–29	0.037^*
6 wk	3.58 (6.06)	0–26
12 wk	3.33 (4.98)	0–20